1. Home
  2. BGX vs STIM Comparison

BGX vs STIM Comparison

Compare BGX & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone Long Short Credit Income Fund

BGX

Blackstone Long Short Credit Income Fund

HOLD

Current Price

$10.71

Market Cap

136.6M

Sector

Finance

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$2.91

Market Cap

120.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGX
STIM
Founded
N/A
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
136.6M
120.4M
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
BGX
STIM
Price
$10.71
$2.91
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
62.1K
1.2M
Earning Date
01-01-0001
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.25
EPS
N/A
N/A
Revenue
N/A
$52,776,000.00
Revenue This Year
N/A
$11.10
Revenue Next Year
N/A
$11.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.38
$0.80
52 Week High
$12.24
$3.44

Technical Indicators

Market Signals
Indicator
BGX
STIM
Relative Strength Index (RSI) 47.98 51.91
Support Level $10.65 $2.67
Resistance Level $10.75 $3.25
Average True Range (ATR) 0.06 0.21
MACD 0.01 -0.04
Stochastic Oscillator 70.27 36.29

Price Performance

Historical Comparison
BGX
STIM

About BGX Blackstone Long Short Credit Income Fund

Blackstone Long-Short Credit Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. The company's seeks to achieve its investment objectives by employing a dynamic long-short strategies in a diversified portfolio of loans and fixed-income instruments of predominantly U.S. corporate issuers, including first and second-lien secured loans (Secured Loans) and high-yield corporate bonds of varying maturities.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Share on Social Networks: